Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Proteome Research

• Publication date

  2012-02-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/pr201014hPMID 22204653
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers.

  2011cited by this paper
• Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.

  2010cited by this paper
• Expression of Progranulin (Acrogranin/PCDGF/Granulin-Epithelin Precursor) in Benign and Malignant Ovarian Tumors and Activation of MAPK Signaling in Ovarian Cancer Cell Line

  2010cited by this paper
• Development and application of mass spectrometric methods for the analysis of progranulin N-glycosylation.

  2010cited by this paper
• ExoCarta: A compendium of exosomal proteins and RNA

  2009cited by this paper
• Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome.

  2009cited by this paper
• Identification of Five Candidate Lung Cancer Biomarkers by Proteomics Analysis of Conditioned Media of Four Lung Cancer Cell Lines*

  2009cited by this paper
• Proepithelin is an autocrine growth factor for bladder cancer.

  2009cited by this paper
• Software tool for researching annotations of proteins: open-source protein annotation software with data visualization.

  2009cited by this paper
• Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth.

  2009cited by this paper
• Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.

  2008cited by this paper
• Identification of collapsin response mediator protein‐2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes

  2008cited by this paper
• Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model

  2008cited by this paper
• Proteomics Analysis of Conditioned Media from Three Breast Cancer Cell Lines

  2007cited by this paper
• Immortalized ovarian surface epithelial cells acquire tumorigenicity by Acrogranin gene overexpression.

  2007cited by this paper
• Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.

  2007cited by this paper
• Prosurvival function of the granulin‐epithelin precursor is important in tumor progression and chemoresponse

  2007cited by this paper
• Cathepsin D is secreted from M-BE cells: its potential role as a biomarker of lung cancer.

  2007cited by this paper
• Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex.

  2006cited by this paper
• Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic Approach*S

  2006cited by this paper
• Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer.

  2006cited by this paper
• Cancer cell‐secreted proteomes as a basis for searching potential tumor markers: Nasopharyngeal carcinoma as a model

  2005cited by this paper
• Feature-based prediction of non-classical and leaderless protein secretion.

  2004cited by this paper
• PC Cell-Derived Growth Factor Expression in Prostatic Intraepithelial Neoplasia and Prostatic Adenocarcinoma

  2004cited by this paper
• Granulin–Epithelin Precursor Overexpression Promotes Growth and Invasion of Hepatocellular Carcinoma

  2004cited by this paper
• Granulin‐epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma

  2004cited by this paper
• Progranulin is a mediator of the wound response

  2003cited by this paper
• The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes.

  2003cited by this paper
• Expression of PC-cell-derived growth factor in benign and malignant human breast epithelium.

  2003cited by this paper
• Prospective study of peritoneal recurrence after curative surgery for gastric cancer

  2003cited by this paper
• The microenvironment of the tumour–host interface

  2001cited by this paper
• Modulation of mouse preimplantation embryo development by acrogranin (epithelin/granulin precursor).

  2000cited by this paper
• Signal Peptide-Dependent Protein Transport inBacillus subtilis: a Genome-Based Survey of the Secretome

  2000cited by this paper
• Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer.

  1992cited by this paper

• Research Progress of Biomarkers in the Early Diagnosis of Gastric Cancer

  2025cites this paper
• Integrated multiomics analysis highlights the immunosuppressive role of granulin precursor positive macrophages in hepatocellular carcinoma

  2025cites this paper
• An Introduction to Analytical Challenges, Approaches, and Applications in Mass Spectrometry–Based Secretomics

  2023cites this paper
• Identification of stromal cell-derived factor 4 as a liquid biopsy-based diagnostic marker in solid cancers

  2023cites this paper
• Plasmonic nanocavity-modulated electrochemiluminescence sensor for gastric cancer exosomal miRNA detection.

  2023cites this paper
• Mechanism and Therapeutic Value of Exosomes in Gastric Cancer

  2023cites this paper
• Identification of secreted proteins by comparison of protein abundance in conditioned media and cell lysates

  2022cites this paper
• Advances in Exosomes in the Detection of Malignant Tumors of the Digestive System

  2022cites this paper
• Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer

  2022cites this paper
• Quantitative MS Workflow for a High-Quality Secretome Analysis by a Quantitative Secretome-Proteome Comparison.

  2021cites this paper
• Synergetic fabrication of hybrid drug formulation using biodegradable tri-block copolymeric liquid nanoparticle delivery for gastric cancer chemotherapy

  2021cites this paper
• Acupuncture Regulates Serum Differentially Expressed Proteins in Patients with Chronic Atrophic Gastritis: A Quantitative iTRAQ Proteomics Study

  2021cites this paper
• Exosomes as an emerging nanoplatform for functional therapeutics

  2021cites this paper
• Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer

  2021cites this paper
• Exosomes: Multiple-targeted multifunctional biological nanoparticles in the diagnosis, drug delivery, and imaging of cancer cells.

  2020cites this paper
• The secrets of protein secretion: what are the key features of comparative secretomics?

  2020cites this paper
• Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer

  2020cites this paper
• Identification of Human Secretome and Membrane Proteome-Based Cancer Biomarkers Utilizing Bioinformatics

  2020cites this paper
• Comparative Secretomics Gives Access to High Confident Secretome Data: Evaluation of Different Methods for the Determination of Bona Fide Secreted Proteins

  2020cites this paper
• A GRN Autocrine-Dependent FAM135B/AKT/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma Progression

  2020cites this paper
• Challenges and Opportunities in Clinical Applications of Blood-Based Proteomics in Cancer

  2020cites this paper
• Upregulation of microRNA‐140‐3p inhibits epithelial‐mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN

  2019cites this paper
• Pitfalls and opportunities in the characterization of unconventionally secreted proteins by secretome analysis.

  2019cites this paper
• Clinical Significance of Serum Vascular Endothelial Growth Factor, Pigment Epithelium–Derived Factor, Tumor Necrosis Factor Alpha, and Progranulin Levels in Patients with Gastric Cancer and Gastric Precancerous Lesions

  2019cites this paper
• Analyzing the Secretome of Gut Microbiota as the Next Strategy For Early Detection of Colorectal Cancer

  2019cites this paper
• Secretome analysis of human bone marrow derived mesenchymal stromal cells.

  2019cites this paper
• Proteomics biomarkers for solid tumors: Current status and future prospects.

  2018cites this paper
• Use of ANGPTL2 mRNA levels in formalin-fixed paraffin-embedded tissues as a biomarker to diagnose gastric cancer and to evaluate the extent of vascular invasion.

  2018cites this paper
• The Cancer Secretome

  2017cites this paper
• Proteomic profiling of the cancer cell secretome: informing clinical research

  2017cites this paper
• Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?

  2017cites this paper
• Bioinformatics Tools for Extracellular Vesicles Research.

  2017cites this paper
• Gastric Cancer Biomarkers in Circulation

  2017cites this paper
• Comparative proteomic analysis of urine and laser microdissected glomeruli in IgA nephropathy

  2017cites this paper
• Extracellular vesicles in breast cancer drug resistance and their clinical application

  2016cites this paper
• In vitro secretomics study of pterygium-derived fibroblasts by iTRAQ-based quantitative proteomics strategy.

  2016cites this paper
• Secretome protein signature of human pancreatic cancer stem-like cells.

  2016influential citation
• Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry

  2016cites this paper
• Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics

  2016cites this paper
• Progress in the development of protein biomarkers of oesophageal and gastric cancers

  2016influential citation
• Recent advances in mass spectrometry-based proteomics of gastric cancer

  2016cites this paper
• Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma

  2015cites this paper
• Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study

  2015cites this paper
• Development of Diagnostic Biomarkers for Detecting Diabetic Retinopathy at Early Stages Using Quantitative Proteomics

  2015cites this paper
• Comparative secretome analysis of rat stomach under different nutritional status

  2015cites this paper
• HCSD: the human cancer secretome database

  2015cites this paper
• A method for establishing human primary gastric epithelial cell culture from fresh surgical gastric tissues.

  2015cites this paper
• Identification of differentially expressed serum proteins in gastric adenocarcinoma.

  2015cites this paper
• Exosomes: Potent regulators of tumor malignancy and potential bio-tools in clinical application.

  2015cites this paper
• Analysis of the differential secretome of nasopharyngeal carcinoma cell lines CNE-2R and CNE-2.

  2015cites this paper
• Angiopoietin-like protein 2 is a potential biomarker for gastric cancer.

  2015cites this paper
• Comparative secretome analysis of rat stomach under different nutritional status.

  2015cites this paper
• From Integrative Omics to Improved Molecular Classification of Head and Neck Cancers

  2015influential citation
• iTRAQ analysis of colorectal cancer cell lines suggests Drebrin (DBN1) is overexpressed during liver metastasis

  2014cites this paper
• Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma.

  2014cites this paper
• Comparative proteomic analysis of renal tissue in IgA nephropathy with iTRAQ quantitative proteomics.

  2014cites this paper
• Proteomic analysis of mouse astrocytes and their secretome by a combination of FASP and StageTip‐based, high pH, reversed‐phase fractionation

  2014cites this paper
• Serum proteomics for gastric cancer.

  2014cites this paper
• Secretomes are a potential source of molecular targets for cancer therapies and indicate that APOE is a candidate biomarker for lung adenocarcinoma metastasis

  2014cites this paper
• Mass Spectrometry-Based Proteomics in Molecular Diagnostics: Discovery of Cancer Biomarkers Using Tissue Culture

  2013cites this paper
• MVP / MR Patients ( n = 24 ) Pooled plasma samples Pooled plasma samples A B C D ProteoMiner Fractionation

  2013influential citation
• Proteomics discovery of biomarkers for mitral regurgitation caused by mitral valve prolapse.

  2013cites this paper
• Serum protein and genetic tumor markers of gastric carcinoma.

  2013cites this paper
• SILAC‐based quantitative proteomic analysis of gastric cancer secretome

  2013cites this paper
• An iTRAQ based quantitative proteomic strategy to explore novel secreted proteins in metastatic hepatocellular carcinoma cell lines.

  2013cites this paper
• Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas

  2013cites this paper
• Sieving through the cancer secretome.

  2013cites this paper
• Quantitative proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLC.

  2013cites this paper
• Global secretome analysis identifies novel mediators of bone metastasis

  2012cites this paper
• Potentially Novel Candidate Biomarkers for Head and Neck Squamous Cell Carcinoma Identified Using an Integrated Cell Line-based Discovery Strategy*

  2012cites this paper
• ExoCarta as a resource for exosomal research

  2012cites this paper